Symbol
MREO on Nasdaq
Investment type
Equity / Ordinary Shares, par value GBP 0.003 per share
Latest Disclosed Shares Owned
38,952,900 shares
Security Ownership %
4.9%
Shares, Excluding Options vs Price
Value, Excluding Options

Mangrove Partners IM, LLC ownership in Mereo BioPharma Group plc Ordinary Shares, par value GBP 0.003 per share (MREO)

14 Nov 2025 - Mangrove Partners IM, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 38,952,900 shares of Mereo BioPharma Group plc Ordinary Shares, par value GBP 0.003 per share (MREO). This represents 4.9% ownership of the company. This is the first filing by MANGROVE PARTNERS IM, LLC disclosing ownership of Mereo BioPharma Group plc Ordinary Shares, par value GBP 0.003 per share (MREO).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.